NCT03962621

A Study of the Efficacy of Erbium:YAG 2940nm in Combination With 1064nm Laser on Facial Rejuvenation

Completed NA Last updated 24 May 2019

What this trial tests

NA trial testing Fotona 4D 1064 nm laser in Facial Rejuvenation in 20 participants. Completed in 1 January 2019.

Timeline

1 January 2017

Primary endpoint
1 January 2019

1 January 2019

Quick facts

Lead sponsor	xjpfW
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	double
Primary purpose	treatment
Enrollment	20
Start date	1 January 2017
Primary completion	1 January 2019
Estimated completion	1 January 2019

Drugs / interventions tested

• Fotona 4D 1064 nm laser
• Fotona 4D 2940 nm laser

Conditions studied

• Facial Rejuvenation — all drugs for Facial Rejuvenation →

Sponsor

xjpfW — full company profile →

Who can join

Adults 35 to 60, any sex, with Facial Rejuvenation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Facial aging is a progressive, multifactor-induced and multidimensional process which is naturally irreversible. The prominent clinical features of skin aging include loss of volume, pigmentation irregularity, low light reflectance, static and dynamic wrinkles, etc.
2. The development of superpulsed CO2 and Erbium: YAG 2940 nm resurfacing lasers was considered as the "gold standard" for the treatment of facial aging \[8,9\]. However, many drawbacks including intraoperative pain, post procedural erythema, edema, high risk of changes of pigmentation and long downtime have drawn concerns to patients and practitioners. Therefore, the facial rejuvenation therapies based on combined modalities to target various factors simutaneously have raised more and more interests.
3. The Fotona 4D laser platform incorporates the long pulsed 1064 nm and 2940 nm lasers, which provides versatile modalities to target various skin aging problems simultaneously. The 1064 nm laser can penetrate deep into the skin to explode pigment particles, destroy blood vessels and heat the dermal collagen by targeting melanin and haemoglobin. The 2940 nm Er:YAG laser in Fotona 4D system integrates a non-ablative Smooth® mode and cold peel SupErficial™ mode. the half-face treated by a 2940 nm laser alone showed a significant improvement on indexes of skin wrinkles, texture, pores and elasticity as compared to the baseline.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.